The InPen is a reusable insulin pen for people living with diabetes. It can be used to deliver insulin, help calculate insulin doses, and estimate carbohydrates for meals. Those under the age of 7 should only use the device with an adult’s supervision. A healthcare provider must prescribe InPen, provide dosage settings, and discuss all potential benefits and risks. Using the device with incorrect therapy settings may lead to severe highs and lows. The InPen should not be used by those unable to test blood glucose levels or the visually impaired. For additional product and important safety information, click here.
The smart insulin pen
The InPen™ system combines smart pen technology and an app to help make managing diabetes easier.
InPen helps reduce the mental math of diabetes management.
How does it work?
The InPen system helps you take the right amount of insulin, at the right time. It calculates personalized meal and correction doses - considering your insulin sensitivity, insulin-to-carb ratio, and active insulin levels for each dose recommendation. The system also logs doses on a mobile app, allowing you to see your dose history on a smartphone.
Learn more about the features that help reduce the mental math of diabetes management.
The dose calculator uses your glucose level and a carbohydrate estimate to recommend the dose that’s right for you.
The meal estimation mode helps you estimate carbohydrates based on your meal size, eliminating the need for exact carbohydrate counting when dosing.
From as little as $35
We don't want cost to be a roadblock to your diabetes management. With the InPen Access Program, you could pay as little as $35*.
*Offer available to eligible patients with commercial insurance. Terms and conditions apply. Learn more at bit.ly/35option.
Lighten your diabetes management load.
Paid partner of Medtronic Diabetes. Thoughts and opinions are her own. Individual results may vary.
Thoughts and opinions are her own. Individual results may vary.
Thoughts and opinions are her own. Individual results may vary.
Thoughts and opinions are their own. Individual results may vary.
Talking to your healthcare provider soon?
Your healthcare team can help you figure out what therapy will work best for you. If you would like to talk about a smart insulin pen at your next appointment, check out our discussion guide.
Looking for more? Join the list.
We’ll send more information about smart pen therapy and occasional product updates directly to your inbox.
Smart MDI. Want to give it a try?
For people who manage their diabetes with insulin injections, Smart MDI helps relieve the physical and mental effort required, by using an ecosystem of smart-enabled technology devices to help make your life a bit easier.
Smart MDI includes a continuous glucose monitor (CGM), an injection port, and the InPen smart insulin pen.
Frequently asked questions
The InPen is the only FDA-cleared smart insulin pen that combines the freedom of Bluetooth® technology and intelligence through an easy-to-use smartphone app, helping people administer correction and mealtime insulin doses.Φ
InPen is a prescription-only device. Eligible patients with commercial insurance may pay as little as $35 per prescribed InPen. Each InPen is reusable for one year. Terms and conditions apply. Learn more.
Yes, you can pair as many InPens as you need to the app. This enables the flexibility for you to have one InPen at home and another at work or school.
Note: Make sure your paired device is within range of your InPen when you dose. Your InPen app will automatically sync doses from all paired InPen(s) when within range.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
Important Safety Information: InPen™
The InPen is a reusable insulin pen for people living with diabetes. It can be used to deliver insulin, help calculate insulin doses, and estimate carbohydrates for meals. Those under the age of 7 should only use the device with an adult’s supervision. A healthcare provider must prescribe InPen, provide dosage settings, and discuss all potential benefits and risks. Using the device with incorrect therapy settings may lead to severe highs and lows. The InPen should not be used by those unable to test blood glucose levels or the visually impaired. For additional product and important safety information, click here.
Important Safety Information: i-Port Advance™ Injection Port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. Prescription required. For more, please see http://www.medtronicdiabetes.com/important-safety-information.
† Prescription required
∆ Humalog® is a registered trademarks of Eli Lilly and Company. Fiasp® and Novolog® are registered trademarks of Novo Nordisk A/S.
Φ The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.